Scientists in lab


Indigo provides an answer to the pressing need for accurate and affordable chronic disease management by providing innovative high-tech solutions for advanced biomarker sensing characterized by the best possible user experience and highest product quality.

Using its nanophotonics technology, Indigo is committed to lighting up the life of millions of people living with chronic disease through innovative medical technologies.


Our mission is to lighten up the lives of people living with chronic disease by enabling accurate continuous multi- metabolite monitoring to improve outcomes, lower costs and enhance quality of life.

scientists in lab coats
Indigo Lab Detail

The Company

Indigo is a pioneer of continuous multi-metabolite monitoring and was founded by Danaë Delbeke and her team in 2016.

Today, the company is developing a continuous multi-metabolite monitoring (CMM®) system for people living with chronic diseases to provide them with access to information on their metabolite levels at any time, without having to wear an external device on their body.

Indigo exploits ground-breaking nanophotonics technology, which was responsible for revolutionizing the Internet, to transform chronic disease management.

Indigo is headquartered in Ghent, Belgium and also has employees based in the US.

Indigo, the color

The color indigo owes its position in the color spectrum to Sir Isaac Newton, the 17th Century mathematician, physicist, astronomer and theologian, who established indigo as the 7th color.

Indigo is neither a primary nor a secondary color. The human eye is almost incapable of detecting indigo and it takes specific sensitivity to identify the color.

For reasons of perfection however, Newton added indigo to the set of six primary and secondary colors (red, orange, yellow, green, blue, violet) to have the spectrum in accordance with music (7 notes), the seven heavenly bodies (planets and sun and moon) known at the time, and the seven days of the week.

Test Chip Detail

Indigo, the color of light that was missing from the spectrum, makes it perfect.

Indigo’s technology relies on light to accurately sense metabolites in the patient.

“Indigo’s technology has the potential to revolutionize the way we monitor and manage a wide range of chronic diseases. It has the power to transform healthcare by providing real-time, continuous multi-metabolite data that will enable patients and healthcare providers to make informed decisions and take proactive steps to improve health outcomes. We believe this sensor has the potential to make a significant impact on the lives of millions of people around the world, and we are proud to be at the forefront of this important work.”

Paul Moraviec

Chairman of the Board

“We are delighted to be part of the further growth and development of Indigo as a long-term investor. The company boasts an excellent management team that has grown from a unique ecosystem that combines UGent’s photonics expertise with imec’s nanoelectronics expertise. We are convinced that Indigo’s sensor can initially make a substantial difference for people with diabetes and see a broader application potential for this mini-spectrometer going forward.”

An Herremans

Member of the Executive Committee at Ackermans & van Haaren



Danaë Delbeke

CEO and Founder

peter j. devlin


emmet lydon

chief operating officer

Arun Venkatasubramanian

Chief Technology Officer

Gijs Klarenbeek

VP Clinical and Medical Affairs

Daniel Verstappen

VP Quality and Regulatory Affairs

Ilse Pensaert

VP Human Resources

paul moraviec

chairman of the board



Scientific Advisory Board



Head of Department of Endocrinology, Diabetes & Metabolism, Faculty of Medicine, University of Ljubljana, Slovenia


Head of Department of Endocrinology, Diabetes & Metabolism, Medical School, University of Montpellier, France


Director of Department of General Pediatrics Endocrinology/Diabetology & Clinical Research, Hannover Medical School, Germany


Head of Department of Endocrinology, Diabetology and Metabolic Disease, University of Antwerp, Belgium


School of Kinesiology & Health Science, York University, Canada


Division of Endocrinology, University of Virginia, USA


Keck School of Medicine, University of Southern California, USA


Indigo has an international syndicate of highly respected investors, led by Fund+ and including Ackermans & Van HaarenThuja CapitalPMVCapricorn Partnersimec.xpandQbic and private investors.

Logo Fundplus
Logo Ackermans en Van Haaren
Logo Thuja Capital
Logo PMV
Capricorn logo
imec xpand logo
Qbic logo


Indigo was founded by Danaë Delbeke and her team in 2016, as a spin-off of Ghent University and imec, Belgium’s global research centre, well known for its advances in the fields of nanoelectronics and digital technologies including silicon photonics.


Indigo has received funding from the European Union’s Horizon 2020 Research And Innovation Programme under Grant Agreement No 811792.

Indigo is supported by Flanders Innovation and Entrepreneurship (Vlaio).

Logo Ghent University
Logo imec
European Flag
Logo Vlaio

Pin It on Pinterest